Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3368 of 6351
-
Can statins and steroids tame CAR-T's brain risks?
Disease control OngoingOpen-label, single-arm, single center pilot study to assess safety and feasibility of administering dexamethasone intrathecally and simvastatin orally during axicabtagene ciloleucel (axi-cel) treatment. Feasibility will be measured by the proportion of patients completing two-thi…
Early phase 1 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Blood and body fluid tests may reveal sepsis risk groups
Knowledge-focused By invitation onlyDetermine the utility of biomarkers measured in blood and body fluid (stool, saliva, tracheal aspirate) when combined with clinical data, for predicting sepsis phenotypes that are associated with poor clinical outcomes. We hypothesize that resistin is a biomarker which provides c…
Sponsor: Milton S. Hershey Medical Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:57 UTC
-
Cancer drug trial halted early – what happened?
Disease control Stopped earlyThe purpose of this study is to evaluate the efficacy and safety of futibatinib in patients with FGFR aberrations in 3 distinct cohorts. Patients will be enrolled into one of 3 cohorts: patients with advanced, metastatic or locally-advanced solid tumors harboring FGFR1-4 rearrang…
Phase 2 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Smart implant aims to dial down chronic pain for years
Symptom relief OngoingThe objective of this multicountry, multicentre, prospective study is to evaluate the long-term clinical effectiveness, safety, and performance of the Evoke System in the treatment of chronic pain of the trunk and/or limbs in a real-world population.
Sponsor: Saluda Medical Pty Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Faricimab shows promise for Long-Term control of diabetic eye disease
Disease control CompletedThis is a multicenter long-term extension study designed to evaluate the long-term safety and tolerability of faricimab administered by intravitreal (IVT) injection at a personalized treatment interval (PTI) to participants who enrolled in and completed one of the two Phase III s…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Could a transplant drug help fight glioblastoma?
Disease control OngoingThis is a phase 0/1 dose-escalation trial to determine the maximum tolerated dose of Mycophenolate Mofetil (MMF) when administered with radiation, in patients with glioblastoma or gliosarcoma.
Phase 1 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Nerve block may reduce Post-Surgery pain in breast cancer patients
Symptom relief CompletedCompare the effect of ropivacaine versus placebo pectoral nerve block (Pecs 1 and 2) on acute pain after tumorectomy plus sentinel lymph node dissection on one day surgery.
Phase 3 • Sponsor: Institut Curie • Aim: Symptom relief
Last updated Jun 26, 2026 19:01 UTC
-
Dads as health heroes: study tests coaching for new parents to curb baby weight gain
Prevention CompletedThe First Heroes study plans to influence weight and health trajectories, modify disease risk, and improve health care services for mother-father-infant triads from racial/ethnic minority and health disparity populations. This study is a two-arm, randomized controlled trial recr…
Sponsor: Massachusetts General Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:31 UTC
-
Could a cancer drug help patients with rare gene changes?
Disease control OngoingThis phase II trial studies how well olaparib works in treating patients with acute myeloid leukemia that has come back (relapsed) or does not respond to treatment (refractory), or myelodysplastic syndrome. Patients must also have a change in the gene called the IDH gene (IDH mut…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Immunotherapy drug could reduce need for surgery in advanced skin cancer
Disease control CompletedThe purpose of this study is to evaluate anti-PD-1 Neoadjuvant therapy in Basal cell carcinoma to provide a better outcome when administered prior to surgery and provide a therapeutic strategy to avoid surgery altogether. The study team will gather information about how Basal cel…
Phase 1 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Gut clues could unlock Sjogren's mystery
Knowledge-focused CompletedThe study aims at defining the role of immune cells derived from the intestine in the pathogenesis of Sjogren's disease. This research might open new therapeutic approaches for the treatment of autoimmune diseases.
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Rabies shot reveals immune secrets in CAR-T cancer survivors
Knowledge-focused CompletedThis phase I trial will use the inactivated rabies virus vaccine to assess immune function in patients who previously underwent B cell targeted chimeric antigen receptor-modified T cell immunotherapy (CARTx). A cohort of healthy volunteers will also be enrolled as a comparator gr…
Phase 1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:58 UTC
-
Can gait training help young people with cerebral palsy walk better?
Symptom relief OngoingThe study design will consist of a cohort of adolescents and young adults with cerebral palsy (CP) that will undergo a gait training protocol. All participants will complete MEG or EEG baseline brain imaging measures of their sensorimotor cortical activity, MRI brain/spinal cord …
Sponsor: Father Flanagan's Boys' Home • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
New decision aid aims to improve opioid treatment choices
Knowledge-focused CompletedThe aim of the study is to test the effectiveness of the Patient Decision Aid for Opioid Use Disorder (PtDA-MAT) by conducting a stepped-wedge cluster-randomized trial in CA H\&SS (stratified by rural vs. non-rural areas) for adults with OUD. Patient outcomes will be tracked by (…
Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Cancer drug parsaclisib gets extended trial for B-Cell patients
Disease control OngoingThis is a Phase 2, multicenter, open-label study to provide continued supply of parsaclisib as monotherapy or in combination therapy with itacitinib, ruxolitinib, or ibrutinib to participants from Incyte-sponsored studies of parsaclisib.
Phase 2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Can stimulating a nerve calm HIV-Related inflammation?
Knowledge-focused CompletedThe study team's prior research has shown that dysfunction of a specific nerve, called the vagus nerve, is associated with small intestinal bacterial overgrowth (SIBO), and that SIBO is associated with signs of inflammation in the blood of people living with HIV (PLWH). This rese…
Phase 1/2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
Spine surgery infection breakthrough? vancomycin powder tested in new trial
Disease control OngoingSurgical site infections (SSI) are not uncommon, especially in specific high-risk groups including spinal deformity and tumor (i.e. metastatic spine surgery) surgery. Well-recognized measures have been adopted to reduce surgical site infection, and the use of topical vancomycin p…
Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Can a Head-Zap ease OCD? small trial hints at hope
Symptom relief CompletedThis is a randomized, double-blind, parallel-group, sham-controlled trial that aims to investigate the effectiveness of transcranial direct current stimulation (TDCS) on improving symptoms, quality of life, depression, and cognitive functions in 39 patients with obsessive-compuls…
Phase 1 • Sponsor: The National Brain Mapping Laboratory (NBML) • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Smart vest could help families keep dementia patients safe at home
Symptom relief CompletedThe purpose of this study is to develop and examine the preliminary effects of a smart cloth care system for facilitating family caregiving for persons with dementia in the home setting. This will be a three-year study, with the first two years to explore the feasibility of such …
Sponsor: Chang Gung Memorial Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
New therapy aims to help transgender and nonbinary people with alcohol problems
Disease control PausedGender minority (GM; transgender and gender non-conforming) individuals experience disproportionately high rates of hazardous drinking and alcohol use disorder (AUD) and are an NIH-designated disparity population (NOT-MD-19-001). Despite marked disparities and unique alcohol risk…
Sponsor: New York State Psychiatric Institute • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC